Objective: To investigate the association between attributes of primary care and polypharmacy. Design: Cross-sectional study. Setting: A primary care practice-based research network in Japan (28 primary care clinics). Participants: Adult outpatients filled out a standardized questionnaire. Main outcome measure: Polypharmacy defined as the use of five or more concurrent prescription or over-the-counter medications. Methods: Attributes of primary care were assessed via patient experience using the Japanese version of Primary Care Assessment Tool (JPCAT). Poisson mixed effects model was used to adjust for clustering within clinics and covariates. Results: Data were analyzed for 544 primary care outpatients. After adjusting for patients' sociodemographic and health characteristics, the JPCAT community orientation score was found to be inversely associated with polypharmacy at the clinic level [risk ratio per 1 standard deviation increase = 0.83; 95% confidence interval (CI), 0.73-0.96; P = 0.008]. Sensitivity analyses using a different definition of polypharmacy showed results similar to those of the primary analyses. Conclusions: We found that a higher level of community-oriented primary care is associated with a lower prevalence of polypharmacy in outpatients at the clinic level. These findings may be useful in developing community-based interventions to minimize polypharmacy.
Introduction
Patient use of multiple medications (polypharmacy) is an increasingly serious quality problem in the health care system. Although there is no formally accepted definition of polypharmacy, it is usually considered to be the concurrent use of at least five medications [1] . Polypharmacy has the potential to influence aspects of safe prescribing, including adverse drug reactions and poor adherence [2, 3] . It can also lead to negative health outcomes, such as falls, cognitive impairment, hospitalization and mortality [4] [5] [6] .
The primary factor leading to polypharmacy is multimorbidity, which is the presence of multiple diseases in one individual [7] . In case of multimorbidity, there might as well be a need for polypharmacy [8, 9] . Because primary care physicians tend to care for a majority of patients with multimorbidity, polypharmacy is recognized as one of the greatest prescribing challenges in primary care [10] . Therefore, a number of studies have investigated the relationship between health care service factors and polypharmacy in the primary care setting [11] [12] [13] [14] . These studies have found that practice structure, clinical work profile, consultation length, perceived patient pressure and the number of primary care physicians a patient consults can determine whether polypharmacy occurs. These findings suggest that attributes essential to effective primary care may play an important role in reducing polypharmacy at the clinic level. However, whether primary care attributes are associated with polypharmacy is uncertain.
Effective primary care incorporates several core attributes: first contact, longitudinality, coordination, comprehensiveness, and family and community orientation. Primary care that fully incorporates these attributes minimizes unnecessary and potentially harmful care [15] . These attributes of effective primary care have been formally incorporated into the Patient-Centered Medical Home in the USA [16] and into the competency of new primary care specialists in Japan. In this study, we aimed to investigate the associations between attributes of primary care and polypharmacy in outpatients at the clinic level.
Methods

Participants and Setting
This study was conducted in a primary care practice-based research network (PBRN) in Japan from October 2015 to February 2016. A PBRN is a group of ambulatory primary care practices that are affiliated with each other in order to investigate research questions related to community-based practice [17] . The PBRN where this study was conducted is part of a national network of primary care clinics belonging to the Japanese Health and Welfare Co-operative Federation and the Japan Federation of Democratic Medical Institutions.
Participating clinics were distributed between urban and rural areas, with the majority being solo practices. These clinics provide preventive care and consultation under the national health insurance system to acutely and chronically ill outpatients or to patients at home, depending on the clinic. Primary care in these clinics is delivered by family physicians, and the majority of patients are elderly. This study was approved by the Institutional Review Board of the Kyoto University Graduate School of Medicine.
A cross-sectional continuous sampling survey was conducted in 28 primary care clinics. A self-administered questionnaire was distributed to all outpatients aged ≥20 years who visited one of the participating clinics within 3-day survey period, and completed surveys were collected via mail. Of those, eligible participants were individuals for whom the clinic serves as their usual source of care (USC).
To identify an individual's USC in this study, the same three questions and algorithm were used in the Japanese version of Primary Care Assessment Tool (JPCAT) [18] that were used in the original Primary Care Assessment Tool Adult Expanded Edition (PCAT-AE) [19] . Those questions were (i) Is there a doctor that you usually go to if you are sick or need advice about your health? (usual source); (ii) Is there a doctor that knows you the best as a person? (knows best); and (iii) Is there a doctor that is the most responsible for your health care? (most responsible). A patient was considered to have a USC if he or she answered yes to any one of the three questions.
Measures
Attributes of Primary Care
Patient experience is the method most commonly used to assess attributes of primary care [20] . We therefore used the JPCAT [18] (Supplementary material) to assess attributes of primary care based on patient experiences in Japan. The JPCAT is based on the PCAT-AE [19] , which was developed by the Johns Hopkins Primary Care Policy Center. This tool is a Japanese version of the PCAT-AE not a simple Japanese translation of the PCAT-AE and consists of fewer items than the original version for better usability. A previous study showed that the JPCAT has good reliability and validity [18] . This 29-item instrument comprises six multi-item subscales addressing the following attributes of primary care: first contact, longitudinality, coordination, comprehensiveness (services available), comprehensiveness (services provided) and community orientation [15] . The scoring system of the JPCAT is structured as follows: each response on a 5-point Likert scale (1 = strongly disagree, 2 = somewhat disagree, 3 = not sure, 4 = somewhat agree and 5 = strongly agree) is reduced by a factor of 1 and multiplied by 25. The score for each of the domains is computed as the mean value for all converted scale scores in that domain. Thus, the domain scores range from 0 to 100 points, with higher scores indicating better performance. In this study, a clinic-level JPCAT score was calculated as the mean of patient-level JPCAT domain scores for each clinic.
Polypharmacy
The primary outcome measure in this study was polypharmacy, which was defined as the concurrent use of five or more prescription or over-the-counter (OTC) medications. Because previous study supported the use of five or more medications in the definition of polypharmacy to estimate the medication-related adverse effects for frailty, disability, falls and mortality [1] . A structured data instrument was used to assess polypharmacy. Patients were asked to provide a count of the medications that were chronically prescribed to them by both their USC and other sources of care, along with number of OTC remedies they used on a daily basis. Externally applied medications were excluded from the count of the concurrently taken medications.
Covariates
Covariates were selected based on a literature review to identify factors that might confound the association between attributes of primary care and polypharmacy. Age, sex, years of education, household income, duration of relationship with USC, number of comorbidities, number of other sources of care and the SF-36 mental health subscale score were all identified as patient-level covariates. The number of comorbidities was assessed with simple counts of diseases in each individual and categorized into four groups: 0, 1, 2 and ≥3. All covariate data were collected using a self-administered questionnaire.
Statistical analysis
Descriptive statistics for continuous data are reported as means and standard deviation; categorical data are reported as frequencies and percentages. For comparisons between characteristics of patients with and without polypharmacy, the Student's t-test was used for continuous data and a chi-square test was used for categorical data.
Multivariate analysis was conducted using a Poisson mixed effects model to determine the association between each JPCAT domain score and the extent of polypharmacy at the clinic level. Clinic was included in the model as a random effect, and patient and clinic-level covariates were included as fixed effects. The model was fitted using maximum pseudo-likelihood estimation and within-clinics correlation was accounted for by using an unstructured covariance matrix. A similar multilevel model was also used in a previous study [21] .
The clinic-level JPCAT domain score was included as the independent variable in the model. In addition, the following patientlevel covariates were included in the model: age, sex, years of education, household income, duration of relationship with USC, number of comorbidities, number of other sources of care, SF-36 mental health subscale score and patient-level JPCAT score centered around the clinic mean (centering within cluster).
For each analysis, a two-sided test of the null hypothesis was conducted using a significance level of P < 0.05, and 95% confidence intervals (CI) were calculated using robust standard errors. Missing data were uncommon for the variables included in the models (2.2-12.5% missing data) and were assumed to be missing at random alone. A mixed effects model was employed as it permitted use of information from all participants, even from those individuals who had some missing data.
To confirm the robustness of the study findings, a sensitivity analysis was also conducted using a different definition of polypharmacy. Because the way in which the medication use is measured varies from one study to the other: it can involve prescribed and/or OTC medications. Each model was re-estimated with polypharmacy defined as the use of five or more prescription medications only, with OTC medications excluded from the medication count.
SPSS version 23 (SPSS, Inc., Chicago, IL, USA) was used for all statistical analyses. We expected a standardized effect size (Cohen's d) of 0.50 for the primary outcome and estimated the minimum sample size of 64 per polypharmacy group at a power of 0.80 [22] .
Results
Of 1939 patients, a total of 644 (33.2%) patients completed the survey. Of these respondents, 23 were excluded because they did not have a USC. Analyses were conducted using the sample of 544 patients who had complete outcome data (Fig. 1) . Table 1 shows the characteristics of the 544 patients. The majority of patients included women (53.7%), aged ≥61 years (83.5%), had multimorbidity (69.9%) and had a relationship of >5 years with a USC (65.4%). The proportion of patients with polypharmacy was 39.2%. Univariate analysis showed a significant association between polypharmacy and age, years of education, household income, duration of relationship with the USC, number of comorbidities and number of other sources of care. Table 2 shows the distribution of clinic-level JPCAT domain scores, which are the means of patient-level scores for each clinic. The domain with the highest score was longitudinality (79.0) and the domain with the lowest score was comprehensiveness (services provided) (44.7). Table 3 shows the results of multivariate analyses using a Poisson mixed effects model to investigate the association between JPCAT domain scores and polypharmacy at the clinic level. After adjustment for possible confounders and within-clinic clustering, the community orientation score was found to be significantly inversely associated with polypharmacy (risk ratio per 1 standard deviation increase = 0.83; 95% CI, 0.73-0.96; P = 0.008). All other associations between JPCAT domain scores and polypharmacy were not statistically significant. Table 4 shows the results of sensitivity analyses using different definitions of polypharmacy (excluding OTC medications). Findings were similar to those of the primary analysis, with the community orientation score being significantly inversely associated with polypharmacy (risk ratio per 1 standard deviation increase = 0.84; 95% CI, 0.72-0.98; P = 0.026).
Discussion
The results of the multivariate analysis showed that the community orientation score was inversely associated with polypharmacy. This association persisted after adjustment for possible confounders and clustering effects. When a sensitivity analysis was conducted using a more stringent definition of polypharmacy, the polypharmacy risk ratio for the clinic-level community orientation score was similar to the risk ratio derived in the primary analysis. Overall, the results showed that a higher level of community-oriented primary care (COPC) was associated with lower prevalence of polypharmacy in outpatients at the clinic level. These findings suggest that primary care provider efforts to reinforce community orientation might help prevent polypharmacy.
COPC is a continuous process whereby primary care is provided to a defined community on the basis of its assessed health needs through the planned integration of public health practice with delivery of primary care services. This linkage of primary care to public health places health promotion and disease prevention is at the forefront of COPC [23] . Although previous studies showed the effectiveness of health promotion in educating patients about polypharmacy, almost all of the interventions in these studies were provided to patients within individual health care organizations [24] . However, these types of organizational interventions might be insufficient for minimizing polypharmacy in patients with multiple morbidities because these patients tend to have multiple sources of care [25] . Polypharmacy is a common issue that should be addressed by the entire community and it might be difficult to solve by individual medical institution alone. Previous study showed the effectiveness of community health education program that include educational presentations about medication use in improving health literacy [26] . Specially, Japan's universal health insurance system provides patients virtually free access to doctors in any type of medical institution [27] . This study setting with many patients having Patients with concurrent use of four or less prescription or over-the-counter medications. c P-value by t-test for continuous variables and chi-square test for categorical data. multiple sources of care may have influenced the association we found.
This study contributes new findings regarding the association between COPC and polypharmacy and might be useful for developing interventions based on the COPC concept to address the problem of polypharmacy. To the best of our knowledge, this study is the first to examine the association between attributes of primary care and polypharmacy in outpatients. Findings were based on data from a nationwide multicenter PBRN study that included a wide range of outpatients in both urban and rural areas. Data on primary care attributes were collected using a modified version of the PCAT, which is a well-established and internationally recognized instrument for measuring primary care attributes. Data on daily medication use were via patient self-report, permitting evaluation of the number of prescription and OTC medications actually being used by each patient. Use of a mixed effects model permitted adjustment for clustering within clinics and permitted appropriate clinic-level multivariate analysis of attributes.
The present study had several potential limitations. First, the patient response rate was low. Although mail collection of completed surveys could be one of the causes of the low response rate, we did not use direct data collection in each clinic in order to prevent the introduction of interviewer bias. In the case of patient experience surveys, there is little evidence for low response rates introducing selective nonresponse bias [28] . Second, although selfreported medication use is commonly used to assess polypharmacy, this method of measurement may have potentially limited validity [29, 30] . In addition, no information on the types of medications taken were collected, thus we could not evaluate appropriateness of medications. Third, data were cross-sectional, and a causal association between community orientation and polypharmacy could not be definitely established. However, the possibility of reverse causality is theoretically low because there is no item for prescriptions or medication use in the JPCAT community orientation domain. Fourth, although we adjusted for number of comorbidities, number of sources of care and SF-36 mental health subscale score, other unmeasured factors related to health care needs may have influenced the findings of this study. In addition, no adjustment was made in the analysis for clustering within primary care physicians. However, the impact on study results is likely limited because the majority of participating clinics are solo practices. Fifth, the study setting was restricted to primary care clinics that have an interest in research and education in primary care. Therefore, although the study involved a nationwide network of primary care clinics, the study results may have limited generalizability.
In conclusion, we found that a higher level of COPC was associated with lower prevalence of polypharmacy among outpatients at the clinic level. These findings may be useful in developing community-based interventions to minimize polypharmacy. 
